Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

Drugs Made In America Acquisition Corp. Units (DMAAU)

10.17
+0.01
+(0.10%)
At close: April 25 at 4:00:00 PM EDT

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Lynn Stockwell CEO & Executive Chairman -- -- 1957
Mr. Glenn Charles Worman Chief Financial Officer -- -- 1959

Drugs Made In America Acquisition Corp. Units

1 East Broward Boulevard
Suite 700
Fort Lauderdale, FL 33301
United States
(954) 870-3099 https://dmaacorp.com
Industry: 
Shell Companies

Description

Drugs Made In America Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses in the pharmaceutical industry. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Corporate Governance

Drugs Made In America Acquisition Corp. Units’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 31, 2025 at 8:05 PM UTC

Drugs Made In America Acquisition Corp. Units Earnings Date

Recent Events

February 24, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 4, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 23, 2025 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

January 22, 2025 at 12:00 AM UTC

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

January 14, 2025 at 12:00 AM UTC

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

January 7, 2025 at 12:00 AM UTC

8-A12B: Trading Registrations

January 6, 2025 at 12:00 AM UTC

S-1/A: Offering Registrations

January 3, 2025 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

December 9, 2024 at 12:00 AM UTC

S-1/A: Offering Registrations

November 25, 2024 at 12:00 AM UTC

S-1/A: Offering Registrations

Related Tickers